4D Biomaterials

About:

4D Biomaterials manufactures polymer resins for 3D-printing high resolution biodegradable medical devices.

Website: https://4dbiomaterials.co.uk/

Top Investors: Innovate UK, SFC Capital, Mercia Fund Managers, DSW Ventures, Boundary Capital Partners LLP

Description:

4Degra® is a unique, patent-protected platform technology and is the ONLY route to 3D-printing high resolution biodegradable medical devices. The technology boosts excellent 3D-printing resolution, unique tunability in strength, elasticity and biodegrability as well as outstanding shape memory properties. Game-changing properties in themselves PLUS the ability to 3D-print medical devices from nano to macro scale will lead to far superior patient experiences compared with the next best alternatives.

Total Funding Amount:

5.68M GBP

Headquarters Location:

Nottingham, Nottingham, United Kingdom

Founded Date:

2018-10-01

Contact Email:

info(AT)4dbiomaterials.co.uk

Founders:

Andrew Dove, Phil Reeves, Philip Smith, Tim O'Connell

Number of Employees:

1-10

Last Funding Date:

2024-07-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai